1. Home
  2. ZLAB vs GPOR Comparison

ZLAB vs GPOR Comparison

Compare ZLAB & GPOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • GPOR
  • Stock Information
  • Founded
  • ZLAB 2013
  • GPOR 1997
  • Country
  • ZLAB China
  • GPOR United States
  • Employees
  • ZLAB N/A
  • GPOR N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • GPOR Oil & Gas Production
  • Sector
  • ZLAB Health Care
  • GPOR Energy
  • Exchange
  • ZLAB Nasdaq
  • GPOR Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • GPOR 3.3B
  • IPO Year
  • ZLAB 2017
  • GPOR N/A
  • Fundamental
  • Price
  • ZLAB $32.54
  • GPOR $184.45
  • Analyst Decision
  • ZLAB Buy
  • GPOR Buy
  • Analyst Count
  • ZLAB 5
  • GPOR 8
  • Target Price
  • ZLAB $54.28
  • GPOR $214.50
  • AVG Volume (30 Days)
  • ZLAB 782.4K
  • GPOR 299.3K
  • Earning Date
  • ZLAB 08-05-2025
  • GPOR 08-05-2025
  • Dividend Yield
  • ZLAB N/A
  • GPOR N/A
  • EPS Growth
  • ZLAB N/A
  • GPOR N/A
  • EPS
  • ZLAB N/A
  • GPOR N/A
  • Revenue
  • ZLAB $418,326,000.00
  • GPOR $1,014,317,000.00
  • Revenue This Year
  • ZLAB $44.07
  • GPOR $56.18
  • Revenue Next Year
  • ZLAB $49.13
  • GPOR $13.45
  • P/E Ratio
  • ZLAB N/A
  • GPOR N/A
  • Revenue Growth
  • ZLAB 43.72
  • GPOR 11.01
  • 52 Week Low
  • ZLAB $16.01
  • GPOR $130.02
  • 52 Week High
  • ZLAB $44.34
  • GPOR $210.32
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 40.19
  • GPOR 43.60
  • Support Level
  • ZLAB $34.26
  • GPOR $170.24
  • Resistance Level
  • ZLAB $35.72
  • GPOR $206.29
  • Average True Range (ATR)
  • ZLAB 1.12
  • GPOR 6.63
  • MACD
  • ZLAB -0.54
  • GPOR -2.54
  • Stochastic Oscillator
  • ZLAB 3.83
  • GPOR 35.49

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About GPOR Gulfport Energy Corporation

Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets predominantly located in the Appalachia and Anadarko basins in the United States. Its principal properties are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.

Share on Social Networks: